# Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging

> **NCT02510456** · — · COMPLETED · sponsor: **Boston Medical Center** · enrollment: 24 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Diffuse Optical Spectroscopy Imaging (DOSI) - Neoadjuvant Chemo (NAC) Cohort
- **DEVICE:** Diffuse Optical Spectroscopy Imaging (DOSI) - Non-NAC Cohort

## Key facts

- **NCT ID:** NCT02510456
- **Lead sponsor:** Boston Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2025-05-08
- **Final completion:** 2025-05-08
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02510456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02510456, "Monitoring Neoadjuvant Chemotherapy Response in Breast Cancer Patients Using Diffuse Optical Spectroscopic Imaging". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02510456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*